Ocrelizumab in Early-Stage Relapsing-Remitting Multiple SclerosisHans‐Peter Hartung, Joep Killestein, Bruno Brochet et al.|Neurology|2024Cited by 15
Subcutaneous ocrelizumab in multiple sclerosis: Results of the Phase 1b <scp>OCARINA</scp> I studyScott D. Newsome, Robert A Bermel, Lawrence Goldstick et al.|Annals of Clinical and Translational Neurology|2024Cited by 3